Uranium Royalty Corp (UROY): Are Investors Missing The Big Picture?

Uranium Royalty Corp (NASDAQ:UROY) does about 2.94M shares in volume on a normal day but saw 3362107 shares change hands in the recent trading day. The company now has a market cap of 257.93M USD. Its current market price is $1.93, marking an increase of 0.52% compared to the previous close of $1.92. The 52 week high reached by this stock is $3.12 whilst the lowest price level in 52 weeks is $1.43.

Uranium Royalty Corp (UROY) has a 20-day trading average at $1.8175 and the current price is -38.14% off the 52-week high compared with 34.97% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.7873 and its 200-day simple moving average is $2.2407. If we look at the stock’s price movements over the week, volatility stands at 4.98%, which increases to 6.03% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.35 to suggest the stock is neutral.

The consensus objective for the share price is $3.55, suggesting that the stock has a potential upside of 45.63% over the period.

B. Riley Securities initiated its price target at $3.50.

The current price level is 6.19%, 7.98%, and -13.87% away from its SMA20, SMA50, and SMA200 respectively, with the UROY price moving below the 50-day SMA on current market day. Uranium Royalty Corp (UROY) stock is up 1.58% over the week and 19.88% over the past month. Its price is -11.87% year-to-date and -25.19% over the past year.

The company’s next earnings report forecasts estimating quarterly EPS at -0.01 and 0.05 for whole year. In addition, estimates put the company’s current quarterly revenue at an average of $13.1M.

To reach the target analysts have set, the stock logically needs to grow 45.63 percent from here.

Outstanding shares total 133.59M with insiders holding 15.69% of the shares and institutional holders owning 28.04% of the company’s common stock. The company has a return on investment of 0.42% and return on equity of 0.45%. The price to earnings ratio (P/E ratio) amounts to 235.37 while the forward price to earnings ratio is 137.07. The beta has a value of 1.42. Price to book ratio is 1.26 and price to sales ratio is 15.17.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.